{
    "nctId": "NCT03850171",
    "briefTitle": "Cancer Adverse Effects PReventIon With Care & Exercise: the CAPRICE Study",
    "officialTitle": "Importance of Exercise Training Therapy Timing With Regard to Cardiotoxicity and Patient Preference in Early Breast Cancer and Lymphoma Patients Undergoing Adjuvant Chemotherapy",
    "overallStatus": "TERMINATED",
    "conditions": "Breast Neoplasm Female, Lymphoma, Cardiotoxicity, Anthracyclines, Physical Activity",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 57,
    "primaryOutcomeMeasure": "Changes from baseline in left ventricular (LV) global longitudinal strain (GLS)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women and men aged 18 years and older\n* Histologically confirmed breast cancer or lymphoma\n* Anth-bC na\u00efve\n* Scheduled for first-line Anth-bC\n* Eastern Cooperative Oncology Group (ECOG) grade 0-2\n* Curative or palliative approach with reasonable life expectancy\n* Willingness to attend exercise sessions twice per week for 12 weeks (24 sessions in total)\n* Informed Consent as documented by signature (Appendix Informed Consent Form)\n\nExclusion Criteria:\n\n* Inability to participate in a 3-month training program\n* Contraindication to maximal CPET\n* Cancer-specific contraindications including safety blood parameters\n* Previous radiotherapy of the mediastinum and/or the the left breast\n* Structural heart disease with reduced left ventricular ejection fraction (EF\\<50%)\n* Valvular heart disease with more than mild regurgitation or stenosis\n* Heart rhythms other than sinus rhythm\n* Pacemaker with permanent ventricular stimulation\n* Antihypertensive medication (e.g. ACE inhibitors/ATII blockers, Ca channel blocker, beta blockers)\n* Known or suspected non-compliance, drug or alcohol abuse\n* Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant\n* Previous enrolment into the current study\n* Enrolment of the investigator, his/her family members, employees and other dependent persons",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}